পদ্ধতির তুলনা করুন

	ইরিটেবল বাওয়েল সিনড্রোমের জন্য রোম IV ডায়াগনস্টিক ক্রাইটেরিয়া	Gastroparesis Cardinal Symptom Index	সরল ক্লিনিকাল কোলাইটিস অ্যাক্টিভিটি ইনডেক্স
ক্ষেত্র	পরিপাকতন্ত্র বিজ্ঞান	পরিপাকতন্ত্র বিজ্ঞান	পরিপাকতন্ত্র বিজ্ঞান
পরিবার	Process / pipeline	Process / pipeline	Process / pipeline
উদ্ভবের বছর	2016	2003	1998
প্রবর্তক	Rome Foundation (multinational expert consensus)	Revicki, D. A., Rentz, A. M., Dubois, D., et al.	Walmsley, R. S., Ayres, R. C., Pounder, R. E., and Allan, R. N.
ধরন	Diagnostic Criteria	Self-report	Clinician-rated
মৌলিক উৎস	Mearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation.	Revicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2003). Development and validation of a patient-assessed gastroparesis symptom severity index. Alimentary Pharmacology & Therapeutics, 18(1), 141–150.	Walmsley, R. S., Ayres, R. C., Pounder, R. E., & Allan, R. N. (1998). A simple clinical colitis activity index. Gut, 43(1), 29–32.
অপর নাম	Rome IV IBS, Rome Criteria	GCSI	SCCAI
সম্পর্কিত	4	4	4
সারসংক্ষেপ	The Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.	The Gastroparesis Cardinal Symptom Index (GCSI) is a validated, patient-reported outcome measure specifically designed to assess symptom severity in gastroparesis. Developed by Revicki and colleagues in 2003, the GCSI captures the three cardinal symptom clusters of gastroparesis: nausea and vomiting, postprandial fullness, and early satiety, plus bloating and stomach distension. The 9-item questionnaire is responsive to treatment changes and is increasingly used in clinical trials and practice to monitor gastroparesis progression and therapy response.	The Simple Clinical Colitis Activity Index (SCCAI) is a practical, bedside tool for assessing disease activity in ulcerative colitis and colonic Crohn's disease. Published in 1998 by Walmsley and colleagues, the SCCAI condenses disease assessment into six items that can be administered in a office visit without laboratory or endoscopic data. It provides rapid, reproducible quantification of disease severity and is ideal for frequent monitoring in routine clinical practice.